Pages that link to "Q33178852"
Jump to navigation
Jump to search
The following pages link to Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. (Q33178852):
Displaying 50 items.
- The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression (Q24536056) (← links)
- P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells (Q24672262) (← links)
- Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine (Q26767415) (← links)
- Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment (Q26783055) (← links)
- Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors (Q26849792) (← links)
- High-dimensional single-cell cancer biology (Q27021173) (← links)
- Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (Q28397002) (← links)
- Effect of cellular quiescence on the success of targeted CML therapy (Q28469312) (← links)
- Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro (Q28477903) (← links)
- Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia (Q28478165) (← links)
- Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells (Q28547244) (← links)
- CD13 is a therapeutic target in human liver cancer stem cells (Q30496324) (← links)
- Persistence to anti-cancer treatments in the stationary to proliferating transition (Q30834504) (← links)
- Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib (Q30873646) (← links)
- High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study. (Q33259951) (← links)
- Reconstruction of cell population dynamics using CFSE (Q33287503) (← links)
- Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells (Q33334266) (← links)
- Cancer stem cell-directed therapies: recent data from the laboratory and clinic (Q33391372) (← links)
- Modeling Tumor Clonal Evolution for Drug Combinations Design (Q33590430) (← links)
- Fluorouracil selectively enriches stem-like leukemic cells in a leukemic cell line (Q33660279) (← links)
- Quiescent fibroblasts exhibit high metabolic activity. (Q33737849) (← links)
- Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells. (Q33747277) (← links)
- Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells (Q33831060) (← links)
- Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML. (Q33834587) (← links)
- Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate (Q33866597) (← links)
- Role of B-cell proliferation in the establishment of gammaherpesvirus latency (Q33908762) (← links)
- Identification and targeting of cancer stem cells (Q33921460) (← links)
- CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma. (Q33994280) (← links)
- Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experience (Q34022125) (← links)
- Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis (Q34076936) (← links)
- SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia (Q34098428) (← links)
- Role of symmetric and asymmetric division of stem cells in developing drug resistance. (Q34165690) (← links)
- The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it? (Q34167708) (← links)
- Models of chronic myeloid leukemia (Q34214855) (← links)
- ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma (Q34343153) (← links)
- Mantle cell lymphoma activation enhances bortezomib sensitivity (Q34360347) (← links)
- Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring (Q34516009) (← links)
- An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. (Q34582568) (← links)
- Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib (Q34832286) (← links)
- Evidence for label-retaining tumour-initiating cells in human glioblastoma (Q34992194) (← links)
- IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients (Q35016953) (← links)
- The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis. (Q35026699) (← links)
- Right on target: eradicating leukemic stem cells (Q35132225) (← links)
- Investigating breast cancer cell behavior using tissue engineering scaffolds (Q35250316) (← links)
- Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells (Q35627994) (← links)
- Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma (Q35635358) (← links)
- Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy. (Q35640320) (← links)
- Leukemia stem cells: the root of chronic myeloid leukemia (Q35650523) (← links)
- The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells (Q35664319) (← links)
- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival (Q35776432) (← links)